Is it possible to manage hypertension and evaluate therapy without ambulatory blood pressure monitoring?

Current Hypertension Reports

Volumn 14, Issue 4, 2012, Pages 366-373

  White, William B ^a   Maraka, Spyridoula ^b  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

Ambulatory blood pressure; Cardiovascular risk; Home blood pressure; Masked hypertension; Morning surge; Nocturnal dipping; Office blood pressure; Target organ damage; White coat hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ARTICLE; BEDTIME DOSAGE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE VARIABILITY; CARDIOVASCULAR RISK; CIRCADIAN RHYTHM; CLINICAL PRACTICE; DISEASE ASSOCIATION; HOME CARE; HUMAN; HYPERTENSION; MASKED HYPERTENSION; MORNING DOSAGE; OUTCOME ASSESSMENT; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PREDICTION; RISK ASSESSMENT; RISK FACTOR; SLEEP PATTERN; SYNDROME DELINEATION; WHITE COAT HYPERTENSION;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE MONITORING, AMBULATORY; CIRCADIAN RHYTHM; HUMANS; HYPERTENSION; RENAL INSUFFICIENCY; RISK; TIME; WHITE COAT HYPERTENSION;

EID: 84865623974     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-012-0277-4     Document Type: Article

References (60)

1. Pickering TG, White WB, Giles TD, et al.: When and how to use self (home) and ambulatory blood pressure monitoring. J Am Soc Hypertens 2010, 4:56-61. Consensus document on clinical and practical recommendations for using home and ambulatory blood pressure monitoring.
2. O'Brien E, Waeber B, Parati G, et al. Blood pressure measuring devices: Recommendations of the European Society of Hypertension. BMJ. 2001;322:531-6. (Pubitemid 32230920)
3. Pickering T. Recommendations for the use of home (self) and ambulatory blood pressure monitoring. American Society of Hypertension Ad Hoc Panel. Am J Hypertens. 1996;9:1-11. (Pubitemid 26060844)
4. Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: Alood pressure measurement in humans: A statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation. 2005;111:697-716. (Pubitemid 40216499)
5. Williams B, Poulter NR, Brown MJ, et al. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens. 2004;18:139-85. (Pubitemid 38425770)
6. Mancia G, De Backer G, Dominiczak A, et al. Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2007;28:1462-536.
7. Imai Y, Otsuka K, Kawano Y, Shimada K, Hayashi H, Tochikubo O, et al. Japanese society of hypertension (JSH) guidelines for selfmonitoring of blood pressure at home. Hypertens Res. 2003;26:771-82. (Pubitemid 37406944)
8. World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens. 1999;17:151-83.
9. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA. 2003;289:2560-72. (Pubitemid 37430158)
10. Clement DL, De Buyzere ML, De Bacquer DA, et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med. 2003;348:2407-15. (Pubitemid 36682819)
11. Dolan E, Stanton A, Thijs L, et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: The Dublin outcome study. Hypertension. 2005;46:156-61. (Pubitemid 40946507)
12. Krause T, Lovibond K, Caulfield M, et al.: Management of hypertension: Summary of NICE guidance. BMJ 2011, 343: D4891. An important summary of the updated NICE guidelines on the management of hypertension and one of the first using evidence to support using ambulatory blood pressure monitoring in clinical practice.
13. Bloch MJ, Basile JN. New British guidelines mandate ambulatory blood pressure monitoring to diagnose hypertension in all patients: Not ready for prime time in the United States. J Clin Hypertens (Greenwich). 2011;13:785-6.
14. White WB. Ambulatory blood-pressure monitoring in clinical practice. N Engl J Med. 2003;348:2377-8. (Pubitemid 36682815)
15. White WB. Circadian variation of blood pressure: Clinical relevance and implications for cardiovascular chronotherapeutics. Blood Press Monit. 1997;2:47-51. (Pubitemid 27166054)
16. Sundberg S, Kohvakka A, Gordin A. Rapid reversal of circadian blood pressure rhythm in shift workers. J Hypertens. 1988;6:393-6.
17. Sternberg H, Rosenthal T, Shamiss A, Green M. Altered circadian rhythm of blood pressure in shift workers. J Hum Hypertens. 1995;9:349-53.
18. White WB, Mansoor GA, Tendler BE, Anwar YA. Nocturnal blood pressure epidemiology, determinants, and effects of antihypertensive therapy. Blood Press Monit. 1998;3:43-51. (Pubitemid 28181629)
19. Di Iorio A, Marini E, Lupinetti M, Zito M, Abate G. Blood pressure rhythm and prevalence of vascular events in hypertensive subjects. Age Ageing. 1999;28:23-8. (Pubitemid 29084058)
20. Harshfield GA, Hwang C, Grim CE. Circadian variation of blood pressure in blacks: Influence of age, gender and activity. J Hum Hypertens. 1990;4:43-7. (Pubitemid 20071245)
21. Sherwood A, Thurston R, Steffen P, et al. Blunted nighttime blood pressure dipping in postmenopausal women. Am J Hypertens. 2001;14:749-54. (Pubitemid 32682240)
22. Cuspidi C, Giudici V, Negri F, Sala C. Nocturnal nondipping and left ventricular hypertrophy in hypertension: An updated review. Expert Rev Cardiovasc Ther. 2010;8:781-92.
23. Pickering TG, Shimbo D, Haas D. Ambulatory blood-pressure monitoring. N Engl J Med. 2006;354:2368-74.
24. Fan HQ, Li Y, Thijs L, et al. Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J Hypertens. 2010;28:2036-45.
25. Gorostidi M, Sobrino J, Segura J, et al. Ambulatory blood pressure monitoring in hypertensive patients with high cardiovascular risk: A cross-sectional analysis of a 20,000-patient database in Spain. J Hypertens. 2007;25:977-84. (Pubitemid 46573116)
26. de la Sierra A, Segura J, Gorostidi M, et al. Diurnal blood pressure variation, risk categories and antihypertensive treatment. Hypertens Res. 2010;33:767-71.
27. de la Sierra A, Redon J, Banegas JR, et al. Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients. Hypertension. 2009;53:466-72.
28. Cuspidi C, Macca G, Sampieri L, et al. Target organ damage and non-dipping pattern defined by two sessions of ambulatory blood pressure monitoring in recently diagnosed essential hypertensive patients. J Hypertens. 2001;19:1539-45. (Pubitemid 32783770)
29. Verdecchia P. Prognostic value of ambulatory blood pressure: Current evidence and clinical implications. Hypertension. 2000;35:844-51. (Pubitemid 30165336)
30. White WB, Larocca GM. Improving the utility of the nocturnal hypertension definition by using absolute sleep blood pressure rather than the "dipping" proportion. Am J Cardiol. 2003;92:1439-41. (Pubitemid 37532567)
31. Mochizuki Y, Okutani M, Donfeng Y, et al. Limited reproducibility of circadian variation in blood pressure dippers and nondippers. Am J Hypertens. 1998;11:403-9. (Pubitemid 28231451)
32. Omboni S, Parati G, Palatini P, et al. Reproducibility and clinical value of nocturnal hypotension: Prospective evidence from the SAMPLE study. Study on Ambulatory Monitoring of Pressure and Lisinopril Evaluation. J Hypertens. 1998;16:733-8. (Pubitemid 28247955)
33. Kario K, White WB. Early morning hypertension: What does it contribute to overall cardiovascular risk assessment? J Am Soc Hypertens. 2008;2:397-402.
34. White WB. Cardiovascular risk and therapeutic intervention for the early morning surge in blood pressure and heart rate. Blood Press Monit. 2001;6:63-72. (Pubitemid 32587662)
35. Wroe SJ, Sandercock P, Bamford J, et al. Diurnal variation in incidence of stroke: Oxfordshire community stroke project. BMJ. 1992;304:155-7.
36. Elliott WJ. Circadian variation in the timing of stroke onset: A meta-Analysis. Stroke. 1998;29:992-6. (Pubitemid 28228162)
37. Casetta I, Granieri E, Portaluppi F, Manfredini R. Circadian variability in hemorrhagic stroke. JAMA. 2002;287:1266-7.
38. Gallerani M, Manfredini R, Ricci L, et al. Chronobiological aspects of acute cerebrovascular diseases. Acta Neurol Scand. 1993;87:482-7. (Pubitemid 23187979)
39. Kario K, Pickering TG, Umeda Y, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: A prospective study. Circulation. 2003;107:1401-6. (Pubitemid 36350739)
40. Li Y, Thijs L, Hansen TW, et al. Prognostic value of the morning blood pressure surge in 5645 subjects from 8 populations. Hypertension. 2010;55:1040-8.
41. Sander GE, Giles TD. Resistant hypertension: Concepts and approach to management. Curr Hypertens Rep. 2011;13:347-55.
42. Den Hond E, Staessen JA, Celis H, et al. Antihypertensive treatment based on home or office blood pressure-The THOP trial. Blood Press Monit. 2004;9:311-4.
43. Stergiou GS, Salgami EV, Tzamouranis DG, Roussias LG. Masked hypertension assessed by ambulatory blood pressure versus home blood pressure monitoring: Is it the same phenomenon? Am J Hypertens. 2005;18:772-8. (Pubitemid 40745260)
44. Liu JE, Roman MJ, Pini R, et al. Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure. Ann Intern Med. 1999;131:564-72. (Pubitemid 29494086)
45. Viera AJ, Hinderliter AL, Kshirsagar AV, Fine J, Dominik R: Reproducibility of masked hypertension in adults with untreated borderline office blood pressure: Comparison of ambulatory and home monitoring. Am J Hypertens 2010, 23:1190-1197. Illustrates that home blood pressure monitoring may not be adequate to detect masked hypertension.
46. Perloff D, Sokolow M, Cowan R. The prognostic value of ambulatory blood pressures. JAMA. 1983;249:2792-8. (Pubitemid 13093711)
47. Fagard RH, Staessen JA, Thijs L, et al. Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Circulation. 2000;102:1139-44.
48. Staessen JA, Thijs L, Fagard R, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA. 1999;282:539-46. (Pubitemid 29380290)
49. Minutolo R, Agarwal R, Borrelli S, et al.: Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease. Arch Intern Med 2011, 171:1090-1098. Demonstrates the importance and utility of using ambulatory blood pressure monitoring in patients with chronic kidney disease as it relates to cardiovascular and renal outcomes.
50. Neutel JM. The importance of 24-h blood pressure control. Blood Press Monit. 2001;6:9-16. (Pubitemid 32269925)
51. White WB, Lacourciere Y, Davidai G. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: Impact on the early morning period. Am J Hypertens. 2004;17:347-53. (Pubitemid 38446850)
52. Hermida RC, Ayala DE, Mojon A, Fernandez JR: Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Chronobiol Int 2010, 27:1629-1651. This article provides information on the effect of timing of hypertension treatment using ambulatory blood pressure monitoring and actigraphy.
53. Graves JW, Nash C, Burger K, Bailey K, Sheps SG. Clinical decision-making in hypertension using an automated (BpTRU) measurement device. J Hum Hypertens. 2003;17:823-7. (Pubitemid 38028639)
54. Pickering TG, Miller NH, Ogedegbe G, et al. Call to action on use and reimbursement for home blood pressure monitoring: Executive summary a joint scientific statement from the american heart association, american society of hypertension, and preventive cardiovascular nurses association. J Am Soc Hypertens. 2008;2:192-202. (Pubitemid 351699670)
55. Mule G, Caimi G, Cottone S, et al. Value of home blood pressures as predictor of target organ damage in mild arterial hypertension. J Cardiovasc Risk. 2002;9:123-9. (Pubitemid 34553592)
56. Tachibana R, Tabara Y, Kondo I, Miki T, Kohara K. Home blood pressure is a better predictor of carotid atherosclerosis than office blood pressure in community-dwelling subjects. Hypertens Res. 2004;27:633-9. (Pubitemid 39534504)
57. Ohkubo T, Imai Y, Tsuji I, et al. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: A population-based observation in Ohasama, Japan. J Hypertens. 1998;16:971-5. (Pubitemid 28367951)
58. Sega R, Facchetti R, Bombelli M, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: Follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation. 2005;111:1777-83. (Pubitemid 40525142)
59. Agarwal R, Andersen MJ. Prognostic importance of clinic and home blood pressure recordings in patients with chronic kidney disease. Kidney Int. 2006;69:406-11. (Pubitemid 43323095)
60. Hodgkinson J, Mant J, Martin U, et al.: Relative effectiveness of clinic and home blood pressure monitoring compared with ambulatory blood pressure monitoring in diagnosis of hypertension: Systematic review. BMJ 2011, 342:d3621. Recent review that provides a systematic evidence-based review on the diagnosis of hypertension with different methods of blood pressure measurement.